Abstract summarizing preclinical characteristics of CBX-250 selected for an oral presentation at the American Association for Cancer Research (AACR) 2024 Annual Meeting Novel T-Bolt™ therapy being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback